{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:27:38Z","timestamp":1790162858524,"version":"4.1.0"},"reference-count":43,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vasc Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prior research has demonstrated that individuals with peripheral artery disease (PAD) often have comorbid opioid use disorder (OUD) and major depressive disorder (MDD), with limited data regarding their impact on readmission outcomes, length of stay, and cost. This study aimed to investigate these healthcare utilization outcomes in patients with PAD who have comorbid OUD and MDD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data were obtained from the National Readmission Database from 2011 through 2018. The study population included all hospitalizations with PAD as the primary or secondary diagnosis, from which hospitalizations with OUD and MDD were extracted using appropriate ICD-9\/10 diagnosis codes. Primary outcomes were 30-day and 90-day readmission, total cost, and total length of stay within the calendar year. We created hierarchical multivariable logistic regression models examining OUD with and without MDD, with a random effect for healthcare facility location.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 2011 to 2018, 13,265,817 weighted admissions with PAD were identified. These admissions were segmented into four categories: No OUD\/No MDD (12,056,466), OUD\/No MDD (323,762), No OUD\/MDD (867,641), and OUD\/MDD (17,948). The group with No OUD\/No MDD was used as the reference group for all subsequent comparisons. Regarding 30-day and 90-day readmissions, patients with OUD\/MDD had odds of 1.14 (95% CI 1.10, 1.18) and 1.09 (95% CI 1.06, 1.13), respectively. Patients with OUD\/No MDD bore the highest median cost of $64,354 (IQR $30,797\u2013137,074), and patients with OUD\/MDD marked the lengthiest median stay of 6.01 days (IQR 2.01\u201313.30).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study found a significant association between these comorbidities and outcomes and therefore calls for targeted interventions and pain management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1358863x241228540","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:11:59Z","timestamp":1708675919000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of comorbid opioid use disorder and major depressive disorder on healthcare utilization outcomes in patients with peripheral artery disease: A National Readmission Database analysis"],"prefix":"10.1177","volume":"29","author":[{"given":"Kelvin","family":"Amenyedor","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Algara","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed Tariq","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Hardt","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Romain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-5672","authenticated-orcid":false,"given":"Carlos","family":"Mena-Hurtado","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-6254","authenticated-orcid":false,"given":"Kim G","family":"Smolderen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA"},{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30255-4"},{"key":"e_1_3_2_3_2","unstructured":"Yost M. The real cost of peripheral artery disease. The Sage Group 2011. https:\/\/www.thesagegroup.us\/wp-content\/uploads\/2021\/02\/Web-Refs.pdf"},{"key":"e_1_3_2_4_2","article-title":"The value of outpatient based labs for endovascular therapy of peripheral artery disease: The Cardiovascular Institute of the South experience","volume":"19","author":"Melvin S","year":"2022","unstructured":"Melvin S. The value of outpatient based labs for endovascular therapy of peripheral artery disease: The Cardiovascular Institute of the South experience. Vasc Dis Manag 2022; 19: E159\u2013E162.","journal-title":"Vasc Dis Manag"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.12.036"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549221123586"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsr.2018.10.011"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2018.12.070"},{"key":"e_1_3_2_9_2","volume-title":"Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use","author":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. Phillips JK, Ford MA, Bonnie RJ (eds). National Academies Press, 2017."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.07.052"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002959"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.11.057"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0560-x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00177-9"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3554"},{"key":"e_1_3_2_16_2","article-title":"Healthcare cost and utilization project (HCUP) statistical briefs","author":"Fingar KR","year":"2006","unstructured":"Fingar KR, Stocks C, Weiss AJ, Steiner CA. Healthcare cost and utilization project (HCUP) statistical briefs. Agency for Healthcare Research and Quality (US). 2006: 2003\u201312.","journal-title":"Agency for Healthcare Research and Quality (US)"},{"key":"e_1_3_2_17_2","unstructured":"Agency for Healthcare Research and Quality. HCUP user support (HCUP-US) https:\/\/www.hcup-us.ahrq.gov\/ (2021 accessed October 10 2023)."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2017.11.071"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013026"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2021-101850"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008235"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007539"},{"key":"e_1_3_2_23_2","volume-title":"Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV)","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). American Psychiatric Association, 1994."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107987"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2757-3"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X17736152"},{"key":"e_1_3_2_28_2","volume-title":"Comorbid PAD and MVD: A retrospective NRD analysis of trends, outcomes, and readmissions","author":"Algara MA","year":"2022","unstructured":"Algara MA. Comorbid PAD and MVD: A retrospective NRD analysis of trends, outcomes, and readmissions. Yale University, 2022."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.09.008"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2021.10.069"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.12.238"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2020.109963"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-018-0017-1"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2022.05.014"},{"key":"e_1_3_2_35_2","unstructured":"National Heart Lung and Blood Institute. Heart disease and depression: A two-way relationship. https:\/\/www.nhlbi.nih.gov\/news\/2017\/heart-disease-and-depression-two-way-relationship (2017 accessed October 16 2023)."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2016.00033"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028332"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.10.092"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.144.suppl_1.13116"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19880277"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/00031348231220582"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01372-0"},{"key":"e_1_3_2_43_2","article-title":"Prevalence and trends of opioid use in patients with depression in the United States","volume":"13","author":"Tumenta T","year":"2021","unstructured":"Tumenta T, Ugwendum DF, Chobufo MD, et al Prevalence and trends of opioid use in patients with depression in the United States. Cureus 2021; 13: e15309.","journal-title":"Cureus"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X16631041"}],"container-title":["Vascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X241228540","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1358863X241228540","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X241228540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:34:43Z","timestamp":1777692883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1358863X241228540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1177\/1358863X241228540"],"URL":"https:\/\/doi.org\/10.1177\/1358863x241228540","relation":{},"ISSN":["1358-863X","1477-0377"],"issn-type":[{"value":"1358-863X","type":"print"},{"value":"1477-0377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}